Eventum Orthopaedics secures £3.8m to revolutionize knee surgeries

Eventum Orthopaedics, a medtech company based in Yorkshire, has secured £3.8 million in funding to advance its QuadSense device, which aids surgeons in accurately cutting and placing the kneecap in knee replacement surgeries. The funding is backed by Mercia Ventures, as part of the Northern Powerhouse Investment Fund II (NPIF II), and includes contributions from private investors and renowned surgeons. Eventum's device, which provides real-time data during surgeries, has received regulatory approvals in the UK and US, and the company is expanding its market reach to additional countries. Eventum plans to use the funds to build product stock and develop new devices for other types of joint replacements, such as shoulders and hips. This marks the third funding round led by Mercia Ventures and NPIF for Eventum, raising their total investment received to over £7 million. The company's founders, John Naybour and Paul Atherton, aim to enhance patient outcomes by informing better clinical decisions. Mercia Ventures' Rob Hornby emphasized the potential for cost reduction in patient dissatisfaction treatments. Lizzy Upton from the British Business Bank highlighted the regional economic benefits fostered by the NPIF II's support. The NPIF II aims to bolster North England's economic growth by providing early-stage finance to small and medium businesses.